Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether/lumefantrine and atazanavir/ritonavir-based antiretroviral regimen in patients living with HIV

The interplay of artemether-lumefantrine (AL) and atazanavir-ritonavir (ATVr) with Cytochrome P (CYP) 3A4 isoenzyme and QTc-interval may spawn clinically significant drug interactions when administered concomitantly. Cardiotoxicity and other adverse effects associated with interaction between AL and...

Descripción completa

Detalles Bibliográficos
Autores principales: Usman, Sikiru Olatunji, Oreagba, Ibrahim Adekunle, Busari, AbdulWasiu, Akinyede, Akinwumi, Adewumi, Ololade, Kadri, Michael Rotimi, Hassan, Olayinka, Fashina, Yinka Adeyemi, Agbaje, Esther Oluwatoyin, Akanmu, Sulaimon Alani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177448/
https://www.ncbi.nlm.nih.gov/pubmed/35693439
http://dx.doi.org/10.1016/j.jsps.2022.02.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177448/
https://www.ncbi.nlm.nih.gov/pubmed/35693439
http://dx.doi.org/10.1016/j.jsps.2022.02.010

Ejemplares similares